Minimum inhibition concentrations (MICs) were determined for ampicillin, ceftiofur, cephalothin, chloramphenicol, enrofloxacin, gentamicin, lincomycin, lincospectin (lincomycin/spectinomycin), neomycin, premafloxacin, spectinomycin, sulfamethoxazole/trimethoprim, and tetracycline against a total of 180 isolates of Actinobacillus pleuropneumoniae, Escherichia coli, and Salmonella choleraesuis (60 each) clinically isolated from pigs on farms in Taiwan from 1994 to 1996. No more than 3 isolates per farm were used. Ceftiofur had the highest activity in vitro against isolates of A. pleuropneumoniae, E. coli, and S. choleraesuis, with MIC 90 values of 0.03, 2, and 1 g/ml, respectively. Premafloxacin was highly active against isolates of A. pleuropneumoniae, E. coli, and S. choleraesuis, with MIC 90 values of 2, 8, and 0.5 g/ml, respectively, which were lower than those with enrofloxacin (MIC 90 8, 32, and 2 g/ml, respectively). Neomycin was moderately active against A. pleuropneumoniae and E. coli, with MIC 90 values of 8 and 64 g/ml, respectively, but was inactive with S. choleraesuis. Gentamicin showed high activity against A. pleuropneumoniae (MIC 90 of 2 g/ml) but was only moderately active with E. coli and S. choleraesuis (MIC 90 of 64 and 32 g/ml). Cephalothin was highly active against isolates of A. pleuropneumoniae (MIC 90 of 1 g/ml) but was inactive with E. coli (MIC 90 of 128 g/ml). Lincomycin had moderate activity (MIC 90 of 32 g/ml) against A. pleuropneumoniae. Chloramphenicol, lincomycin, and tetracycline were inactive with E. coli and S. choleraesuis (MIC 90 Ͼ 128 g/ml).
During the 1990s, pig respiratory disease complex (PRDC) emerged in Taiwan as the most important disease of swine. Porcine respiratory and reproductive syndrome virus, swine influenza virus, hog cholera virus, pseudorabies virus, Actinobacillus pleuropneumoniae, Salmonella choleraesuis, Escherichia coli, Pasteurella multocida, Streptococcus suis type II, and Mycoplasma hyopneumoniae were the most commonly isolated viral and bacterial agents from clinical PRDC cases in Taiwan. [2] [3] [4] 9 Although sound management, sanitation, nutrition, and vaccination are vital to successful prevention and control of PRDC on pig farms, appropriate selection and use of antimicrobials for the treatment and control of bacterial infections is the key to avoiding economic loss. [2] [3] [4] 9 Among these bacterial pathogens, A. pleuropneumoniae, S. choleraesuis, and E. coli are particularly troublesome since they can induce pneumonia and acute septicemia with high mortality and can acquire resistance to antimicrobials. Escherichia coli predominated in suckling pigs, S. choleraesuis was found in nursery and grower pigs, and A. pleuropneumoniae was encountered most frequently in grower to finisher pigs.
The purpose of this study was to investigate the susceptibility of A. pleuropneumoniae, S. choleraesuis, and E. coli to ampicillin, ceftiofur, cephalothin, chloramphenicol, enrofloxacin, gentamicin, lincomycin, lincospectin (lincomycin/spectinomycin), neomycin, premafloxacin, spectinomycin, sulfamethoxazole/trimethoprim, and tetracycline. All except ceftiofur a were purchased from a single source. b A total of 180 porcine isolates were tested in the study. Among them were 60 isolates of each of A. pleuropneumoniae, S. choleraesuis, and E. coli from clinical cases on pig farms in Taiwan from 1994 to 1996. No more than 3 isolates per farm were used, and they were identified by conventional methods. 12 National Committee for Clinical Laboratory Standards (NCCLS)-recommended American Type Culture Collection (ATCC) isolates, E. coli ATCC 25922, Staphylococcus aureus ATCC 25923, Enterococcus faecalis ATCC 29212, A. pleuropneumoniae ATCC 27090, and Pseudomonas aeruginosa ATCC 27853, were used as reference strains for quality control. 8, 10 Agar-dilution minimum inhibition concentration (MIC) testing was performed as previously described. 8, 10 Mueller-Hinton agar c was used for E. coli and S. choleraesuis and veterinary fastidious agar 10 was used for A. pleuropneumoniae. Inoculum was dispensed with a replicator d with 3-mm pins according to the manufacturer's instructions. The MICs of various antimicrobials to swine bacterial pathogens have been compared in several countries. 1, 13 Because antimicrobial resistance is also a serious problem for the swine industry in Taiwan, the MIC test was performed using 3 bacterial species, A. pleuropneumoniae, E. coli, and S. choleraesuis isolated from pigs. The in vitro activity of various antimicrobials to Taiwanese swine isolates of A. pleuropneumoniae, E. coli, and S. choleraesuis are listed in Tables 1, 2, and 3, respectively. The MICs for the isolates tested are summarized in Table 4 . Ceftiofur had the highest activity in vitro against isolates of A. pleuropneumoniae, E. coli, and S. choleraesuis, with MIC 90 values of 0.03, 2, and 1 g/ml, respectively. Ceftiofur was highly active against cattle and swine respiratorydisease pathogens. 13, 15 Minimum inhibition concentrations of 2 g/ml were obtained with E. coli, which is, apparently, higher than previous reports. 13, 15 Whether the difference is due to emerging resistance secondary to heavy use of this antimicrobial in Taiwan is unclear.
The fluoroquinolones generally exhibit activity against Gram-negative bacteria. 11 Of these, premafloxacin was highly active with A. pleuropneumoniae, E. coli, and S. choleraesuis, with MIC 90 values of 2, 8, and 0.5 g/ml, respectively. Enrofloxacin (8, 32, and 2 g/ml, respectively) showed weaker activities than did premafloxacin. Enrofloxacin is an efficacious agent for treatment of swine bacterial disease in the United States and Europe. 1, 7, 13, 14 However, antimicrobial resistance has been well documented since enrofloxacin was approved for use in animals in Taiwan. 4 Again, this may be due to heavy use of enrofloxacin in the swine industry in Taiwan.
Neomycin was moderately active against A. pleuropneumoniae and E. coli, with MIC 90 values of 8 and 64 g/ml, respectively, but was inactive with S. choleraesuis. Gentamicin showed significant activity with A. pleuropneumoniae (MIC 90 of 2 g/ml) but was only moderately active with E. coli and S. choleraesuis (64 and 32 g/ml, respectively). Aminoglycosides are poorly absorbed following oral administration, bind to a low extent to plasma proteins (less than 25%), and show low efficiency in penetrating cellular barriers and entering cells. These antibiotics can produce varying degrees of vestibular damage (streptomycin, gentamicin) or cochlear damage (amikacin, kanamycin, neomycin). In patients with prolonged therapy and excessively high serum concentrations, aminoglycosides (especially neomycin and gentamicin) can also cause acute renal tubular necrosis. 11 Therefore, these antibi- otics have certain limitations to their use in the treatment of bacterial infections.
Cephalothin, a first-generation cephalosporin, 11 was highly active against isolates of A. pleuropneumoniae (MIC 90 of 1 g/ml), moderately active with S. choleraesuis (MIC 90 of 32 g/ml), but inactive with E. coli (MIC 90 of 128 g/ml). The lincomycin-spectinomycin combination creates synergetic effects if the 2 antibiotics are present in the proper ratio and the appropriate type of salts of both antibiotics are employed. 5, 13 Lincomycin was moderately active (MIC 90 of 32 g/ml) with A. pleuropneumoniae but inactive against E. coli and S. choleraesuis (MIC 90 Ͼ128 g/ml). These data are similar to the results of others that indicated lincomycin and spectinomycin are not very efficacious against A. pleuropneumoniae and S. choleraesuis. 6 Chloramphenicol and tetracycline were highly active against A. pleuropneumoniae (MIC 90 of 15 and 14 g/ml, respectively) but inactive against S. choleraesuis and E. coli.
Ampicillin was inactive against A. pleuropneumoniae, E. coli, and S. choleraesuis (MIC 90 of 108, Ͼ128, and Ͼ128 g/ml, respectively). Sulfamethoxazole/trimethoprim, widely used in the swine industry in Taiwan, had relatively weak activity against A. pleuropneumoniae, E. coli, and S. choleraesuis (MIC 90 of 85, Ͼ128, and Ͼ128 g/ml, respectively); these MIC 90 values are higher than those reported previously. 6, 8, 13 In conclusion, ceftiofur and premafloxacin were highly active; enrofloxacin and gentamicin were highly to moderately active against the isolates of A. pleuropneumoniae, E. coli, and S. choleraesuis; cephalothin lincomycin, lincospectin, chloramphenicol, and tetracycline were highly to moderately active against A. pleuropneumoniae only; neomycin had moderate activity with A. pleuropneumoniae and E. coli; the oth-er antibacterial agents tested had no activity against these 3 swine pathogens. 
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